<SEC-DOCUMENT>0001193125-24-218929-index.html : 20240913
<SEC-HEADER>0001193125-24-218929.hdr.sgml : 20240913
<ACCEPTANCE-DATETIME>20240913164537
ACCESSION NUMBER:		0001193125-24-218929
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240913
DATE AS OF CHANGE:		20240913
EFFECTIVENESS DATE:		20240913

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bicara Therapeutics Inc.
		CENTRAL INDEX KEY:			0002023658
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282113
		FILM NUMBER:		241298370

	BUSINESS ADDRESS:	
		STREET 1:		245 MAIN STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-785-8308

	MAIL ADDRESS:	
		STREET 1:		245 MAIN STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d615672ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d615672ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d615672dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d615672dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d615672dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d615672dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d615672dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d615672dexfilingfees.htm

</DOCUMENT>
</SEC-DOCUMENT>